Last reviewed · How we verify
NCT05326893
The Preventive Effects of Neurodynamic Mobilisation
NA trial testing Femoral nerve neurodynamic mobilization in Delayed Onset Muscle Soreness in 34 participants. Completed in 13 May 2022.
20 October 2020
Quick facts
| Lead sponsor | Uğur Sözlü |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 34 |
| Start date | 20 February 2020 |
| Primary completion | 20 October 2020 |
| Estimated completion | 13 May 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Femoral nerve neurodynamic mobilization
- Femoral nerve placebo neurodynamic mobilization
Conditions studied
- Delayed Onset Muscle Soreness — all drugs for Delayed Onset Muscle Soreness →
Sponsor
Uğur Sözlü
Who can join
Adults 18 to 32, male only, with Delayed Onset Muscle Soreness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In the study, 34 healthy sedentary male volunteers were randomly divided into two groups as NM (n = 17) and SHAM-NM (n = 17). After the initial evaluation of the individuals, femoral nerve NM and placebo NM techniques were administered three sets a day with ten repetitions for three days a week for three weeks. Three days after the end of the applications, the second evaluations were made and the DOMS creation protocol for the quadriceps femoris (QF) muscle was initiated. In order to trigger DOMS in individuals, 30 sets and 10 repetitions of eccentric knee extension (35°-95° flexion angles, 30°/sec speed) were performed on the dominant lower extremity with an isokinetic dynamometer. Baseline evaluations were repeated immediately after the DOMS protocol, and at hours 24, 48, and 72. During evaluations, muscle damage (serum creatine kinase (CK), lactate dehydrogenase (LDH), and inflammation (interleukin-6 (IL-6), tumor necrosis factor-alpha) biomarkers, pain (activity), pressure pain threshold, and performance (one-leg jump, vertical jump) parameters were measured.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Preventive effect of the neurodynamic mobilization technique on delayed onset of muscle soreness: a randomized, single-blinded, placebo-controlled study.
Sozlu U, Basar S, Semsi R, Akaras E, et al · · 2025 · cited 2× · PMID 40349018 · DOI 10.1186/s12891-025-08723-8
Verify or expand the search:
- PubMed search for NCT05326893
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Delayed Onset Muscle Soreness
Currently open trials in the same condition.
- NCT06815367 — Pneumatic Compression vs Blood Flow Restriction for Muscle Recovery · NA · recruiting
- NCT04128670 — Effects of Kinesio Tape on Delayed Onset Muscle Soreness · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05326893 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uğur Sözlü
- Last refreshed: 4 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05326893.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing